MediciNova Announces Abstract Regarding Results of a Clinical Trial of MN-166 (ibudilast) in Glioblastoma Accepted for Presentation at the 2024 American Society of Clinical Oncology Annual Meeting (2024 ASCO)

Written by Customer Service on April 2, 2024. Posted in Public Companies.

LA JOLLA, Calif., April 02, 2024 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that an abstract regarding results of a clinical trial of MN-166 (ibudilast) in glioblastoma (GBM) has been selected for an oral presentation at the American Society of Clinical Oncology (2024 ASCO) Annual Meeting to be held May 31 – June 4, 2024 in Chicago. The oral presentation will be presented by one of the investigators of this clinical trial, Gilbert Youssef, M.D., Attending Physician at Harvard Medical School, Center for Neuro-Oncology at Dana-Farber Cancer Institute and Brigham and Women’s Hospital. The presentation details are as follows: Abstract Number: 2106 Title: Phase 1b/2a study...

Sientra Announces Completion and Winning Bidders of its Section 363 Sales Auction

Written by Customer Service on April 2, 2024. Posted in Mergers And Acquisitions.

Tiger Aesthetics Medical, LLC is the successful bidder for certain assets used in Sientra’s breast reconstruction and augmentation business Nuance Intermediary, LLC is the successful bidder for substantially all of the assets used in Sientra’s BIOCORNEUM scar treatment business IRVINE, Calif., April 02, 2024 (GLOBE NEWSWIRE) — Sientra, Inc. (“Sientra” or the “Company”) announced that, following the completion of its Section 363 sales auction, Tiger Aesthetics Medical, LLC (“Tiger”) has been declared the successful bidder for certain of the assets of Sientra used in its breast reconstruction and augmentation business. As consideration for the acquisition, Tiger will pay a cash consideration of $42.5 million as well as assume certain liabilities of the Company, including up to $7 million in cure costs for certain assumed contracts,...

NOVONIX Limited and Lithium Energy Limited to Combine Natural Graphite Interests with Intention to Take Combined Business Public

Written by Customer Service on April 2, 2024. Posted in Public Companies.

NOVONIX Limited (“NOVONIX”) and Lithium Energy Limited (“LEL”) to contribute their natural graphite exploration interests into a new company, Axon Graphite Limited (“Axon”) Shares of Axon to be offered through an initial public offering (“IPO”) and listed on the Australian Securities Exchange (“ASX”) NOVONIX and LEL each will retain up to 28.57% ownership of Axon following the planned IPO Creates world class, large-scale natural flake graphite project Realises value for the shareholders of both NOVONIX and LEL Eligible NOVONIX and LEL shareholders to be given priority in the IPO BRISBANE, Australia, April 03, 2024 (GLOBE NEWSWIRE) — NOVONIX Limited (NASDAQ: NVX, ASX: NVX) (“NOVONIX” or “the Company”), a leading battery materials and technology company, today announced that it has signed a definitive agreement under which its...

Mayfair Acquisition Corp. Announces Change to Board of Directors

Written by Customer Service on April 2, 2024. Posted in Public Companies.

VANCOUVER, British Columbia, April 02, 2024 (GLOBE NEWSWIRE) — Mayfair Acquisition Corp. (TSXV: MFA.P) (“Mayfair” or the “Company“) announces that it has accepted Athur Regan’s resignation as a director of Mayfair for personal reasons. Mr. Regan has been a member of the board since the Company’s inception and the Company thanks Mr. Regan for his many contributions during his tenure. About Mayfair Acquisition Corp. Mayfair was incorporated on May 5, 2021 pursuant to the provisions of the BCBCA and is a Capital Pool Company (as defined in the Manual) listed on the TSXV and a reporting issuer in the Provinces of British Columbia, Alberta and Ontario. Mayfair has no commercial operations and no assets other than cash. Mayfair’s only business is to identify and evaluate assets or businesses with a view...

LGI Homes Named a Top Workplace for the Fourth Consecutive Year

Written by Customer Service on April 2, 2024. Posted in Public Companies.

LGI HOMES NAMED A TOP WORKPLACE FOR THE FOURTH CONSECUTIVE YEAR LGI Homes, one of the nation’s largest and most recognized homebuilders, received the 2024 Top Workplace USA award issued by Energage and USA Today. This is LGI Homes’ 4th consecutive year to receive this distinction. THE WOODLANDS, Texas, April 02, 2024 (GLOBE NEWSWIRE) — LGI Homes, Inc. (NASDAQ: LGIH), one of the nation’s largest and most recognized homebuilders, announced today that it received the 2024 Top Workplace USA award issued by Energage and USA Today. This is LGI Homes’ 4th consecutive year to receive this distinction. “It is a tremendous honor to be recognized as a 2024 Top Workplace USA for the fourth consecutive year,” said Eric Lipar, Chairman and Chief Executive Officer of LGI Homes. “At LGI Homes, we are focused on maintaining a positive environment...

5E Advanced Materials Commences Commercial Production At 5E Boron Americas Complex

Written by Customer Service on April 2, 2024. Posted in Public Companies.

Full plant commissioning and initiation of commercial boric acid production marks the achievement of significant operational and strategic milestone HESPERIA, Calif., April 02, 2024 (GLOBE NEWSWIRE) — 5E Advanced Materials, Inc. (Nasdaq: FEAM) (ASX: 5EA) (“5E” or the “Company”), a boron and lithium company with U.S. government Critical Infrastructure designation for its 5E Boron Americas Complex, today announced the Company’s operations team has successfully commissioned the facility and has launched full commercial operations. The Company began well-field injection on January 1st, 2024. Key Highlights: 5E Boron Americas Complex is fully commissioned and has now transitioned to operational status. Final electrical work was completed by external engineering contractors as of March 15th. Over 50,000 gallons of PLS has been accumulated...

Heritage Cannabis Obtains Creditor Protection to Pursue Restructuring and Sales Process

Written by Customer Service on April 2, 2024. Posted in Public Companies.

Toronto, ON, April 02, 2024 (GLOBE NEWSWIRE) — Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) (“Heritage” or the “Company”), today announces that the Company and its subsidiaries sought and obtained an order for creditor protection (the “Initial Order”) from the Ontario Superior Court of Justice (Commercial List) (the “Court”) pursuant to the Companies’ Creditors Arrangement Act (the “CCAA”). The difficult but necessary decision to commence CCAA proceedings was made after careful consideration of the Company’s financial position, while evaluating all available alternatives and engaging in significant consultation with legal and financial advisors. Additionally, on April 1, 2024, the Company’s senior secured lender, BJK Holdings Ltd. (the “Lender”), made demand to the Company for payment in full of certain indebtedness...

Financial Results for the Year Ended December 31, 2023

Written by Customer Service on April 2, 2024. Posted in Earnings Releases And Operating Results.

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, April 02, 2024 (GLOBE NEWSWIRE) — Helios Fairfax Partners Corporation (TSX: HFPC.U) today announced its financial results for the year ended December 31, 2023. All dollar amounts in this news release are expressed in U.S. dollars except as otherwise noted. The financial results are derived from the annual consolidated financial statements prepared using the recognition and measurement requirements of International Financial Reporting Standards as issued by the International Accounting Standards Board (“IFRS Accounting Standards”), except as otherwise noted. Management Commentary “2023 was a pivotal year for Helios Fairfax Partners, as we successfully exited the majority of our Legacy Non-Core Assets, generating $62.7 million of liquidity...

FibroGen Announces Topline Results from Phase 1 Monotherapy Study of FG-3246 in Patients with Metastatic Castration-Resistant Prostate Cancer

Written by Customer Service on April 2, 2024. Posted in Public Companies.

FG-3246 demonstrated efficacy in adenocarcinoma selected cohorts receiving biologically active doses of FG-3246 at ≥ 1.2 mg/kg in heavily pre-treated, biomarker unselected patients: Median radiographic progression free survival of 8.7 months PSA50 response in 36% of patients Confirmed radiographic objective response rate of 20%, with a median duration of response of 7.5 months FG-3246 demonstrated an acceptable safety profile; adverse events consistent with those observed in other antibody drug conjugate therapies with a MMAE payload Company plans to meet with the U.S. Food and Drug Administration (FDA) to discuss development pathway; Phase 2 initiation is anticipated in 2H 2024 SAN FRANCISCO, April 02, 2024 (GLOBE NEWSWIRE) — FibroGen, Inc. (NASDAQ: FGEN) today announced topline data from the Fortis Therapeutics-sponsored...

Sow Good Appoints Brendon Fischer as Interim Chief Financial Officer

Written by Customer Service on April 2, 2024. Posted in Public Companies.

IRVING, Texas, April 02, 2024 (GLOBE NEWSWIRE) — Sow Good Inc. (OTCQB: SOWG) (“Sow Good” or “the Company”), a trailblazer in the freeze dried candy and treat industry, announced today that Brendon Fischer has been appointed as the Company’s interim chief financial officer (CFO), following the resignation of the Company’s former CFO, Keith Terreri. Fischer’s appointment is effective as of April 2, 2024. Fischer first joined the Sow Good team in June 2023, bringing over 20 years of leadership experience in financial analysis, shareholder communications, and regulatory compliance with public and private companies. His previous company coverage spans several industries, including food and beverage, consumer, packaging, healthcare, energy, technology, and gaming. Before joining Sow Good, Fischer served as the chief investment...

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

Day: April 2, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice